Regarding ACEIs, clinical trials have shown beneficial effects on endothelial function in patients with hypertension and other cardiovascular diseases, however, there are few studies evaluating the effect of treatment with this class on the reduction of CRP levels (Table 1). The gene discussed is CRP; the disease is Hypertension.